Wide Open Agriculture (ASX: WOA) has received a five-tonne order for its lupin protein from Univar Solutions China for use in ...

Lupin shares have gained for eight consecutive trading sessions as of Tuesday's close. The last time the stock gained for eight consecutive sessions was between December 23, 2024 to January 1, 2025.

Billionaires' Bunker is set to premiere on Netflix this week and fans are already asking if the new show is connected to ...

The market may remain consolidative with rangebound trading until the August high is decisively broken. Below are some ...

Lupin Manufacturing Solutions has announced that Empagliflozin API, manufactured at its Vizag facility, has received CADIFA ...

The market may consolidate, but overall, the trend remains favourable for bulls. Below are some short-term trading ideas to ...

Microsoft has introduced Edge Game Assist, a seamless, full-featured in-game browser that will soon be available to all. If you want to use Microsoft Edge Game Assist while playing games in Windows 11 ...

Global brokerage Investec upgraded Lupin to a ‘buy’ from the previous ‘hold’ and also lifted its price target by 8% to ₹2,265. The revised target implies a potential upside of about 14% from ...

Lupin shares trade at Rs 1,979.70, showing early reversal signs and poised to break the falling trend line above Rs 2,000.

Sun Pharma and Lupin pursue regulatory approval for oral weight-loss drugs, potentially reshaping treatment access.

Indias top drugmakers, Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN), are moving closer to developing ...

The medicine had estimated annual sales of $190 million in the US, Lupin said, citing IQVIA moving annual toal July 2025 data ...